FDA Issues Warning for Valsartan Contamination
FDA Warning On June 13, 2018, the FDA issued a warning that alerted healthcare professionals to contamination in the product Valsartan. The contamination contained “impurities in certain commonly prescribed heart medicines.” Companies Involved Some of the companies involved include Zhejiang Huayi Pharmaceutical Co., Ltd. (ZHP), which is a Chinese-based manufacturer, Torrent, Teva, and Aurobindo. The
Read More
FDA Sweeps Heart Medication Cancer Concerns Under the Rug
The FDA released another alert about their investigation into the carcinogens recently uncovered in valsartan, Losartan and irbesartan medications. In typical FDA fashion, the commissioner said that the agency is still investigating but described the impact as small. This is very dismissive to the thousands of people who may have cancer due to their slip up in the
Read More
Heart Medication Recall Expands Again
For the second time this month, heart medication recall expands again. Torrent Pharmaceuticals discovered that Losartan, a drug used to treat high blood pressure, a blood pressure-related heart problem and diabetes-related kidney issues tested positive for N-nitrosodiethylamine (NDEA). Now, in addition to the 10 lots of Losartan potassium tablets and six lots of Losartan, the FDA has
Read More
Truth Behind the Heart Medication Recalls
In July 2018, the FDA began many heart medication recalls. The government agency discovered after inspections of factories in China and India that the medications contained deadly carcinogens. Americans are scared that the medications desperately needed to live a healthy life could have been unknowingly exposing them to cancer for years. Uncovering the Carcinogen In
Read More
Another Blood Pressure Medication Recall
Another blood pressure medication recall has happened after the company detected trace amounts of a cancer-causing chemical, N-nitrosodiethylamine (NDEA). The Food and Drug Administration announced Aurobindo Pharma USA, Inc. is voluntarily recalling 80 lots of Amlodipine Valsartan Tablets, Valsartan HCTZ Tablets, and Valsartan Tablets. About NDEA NDEA can exist naturally in certain foods and drinking
Read More
Valsartan Cancer Contamination Could Happen Again
This year thousands of American consumers are shocked to learn that their heart medication could have caused their cancer as multiple recalls keep occurring. However, what happened at Zhejiang Huahai Pharmaceutical could easily not only happen again, but it is possible to happen in the United States, too. About Valsartan Manufactured by Major Pharamascetucials, Teva
Read More
FDA Recalls All Amlodipine/Valsartan Medications Due to Cancer Risk
The FDA has recalled all lots of amlodipine/valsartan combination tablets and amlodipine/valsartan/hydrochlorothiazide combination tablets in the United States. The manufacturer found more n-nitroso-diethylamine (NDEA) in the medication. NDEA is a probable human carcinogen. This is the fourth recall stemming from the discovery of the cancer-causing agent starting in May. About Valsartan Manufactured by Major Pharamascetucials,
Read More
Third Heart Medication Recall Due to Cancer Risk
The FDA announced a third heart medication recall. The agency found impurity N-nitrosodiethylamine (NDEA) in losartan potassium hydrochlorothiazide tablets. The International Agency for Research on Cancer warns that NDEA is a human carcinogen. About NDEA NDEA can exist naturally in certain foods and drinking water. However, it can also be in air pollution and
Read More
The FDA’s Shocking NDMA Valsartan Test Results
The FDA continues to investigate the presence of impurities in valsartan products used to treat high blood pressure and heart failure. Recently, the agency identified the impurities N-Nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA) in certain valsartan products and have now posted the quantity of NDMA in valsartan medications. The results are shocking. About Valsartan Manufactured by Major
Read MoreWhat To Do After Valsartan Cancer Diagnosis
As many as 1 out of 500 people in the United States using the heart medication, valsartan could develop cancer within a year of taking the drug. It is important to know the next steps after diagnosed with cancer from valsartan use. About Valsartan Manufactured by Major Pharamascetucials, Teva Pharmaceuticals, and other companies, valsartan
Read More